https://doi.org/10.1200/jco.2012.44.9694
C
Chunyan Song
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
168
Papers
3.3K
Citations
26
h-index
49
i10-index
Chunyan Song is an academic researcher from Shihezi University. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Breast Cancer Treatment Studies & Fungal Biology and Applications. The author has an h-index of 26, co-authored 143 publications.
ORCID: 0000-0002-3450-7147Papers by this author
worksPhase II Randomized Study of Trastuzumab Emtansine Versus Trastuzumab Plus Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer
2013 · Journal of Clinical Oncology · 390 citations
Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study
2019 · Journal of Clinical Oncology · 242 citations
https://doi.org/10.1200/jco.19.00882
Deep learning-enabled pelvic ultrasound images for accurate diagnosis of ovarian cancer in China: a retrospective, multicentre, diagnostic study
2022 · The Lancet Digital Health · 169 citations
https://doi.org/10.1016/s2589-7500(21)00278-8
Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE
2021 · Annals of Oncology · 119 citations
https://doi.org/10.1016/j.annonc.2021.04.011
Frequency and barriers of reporting workplace violence in nurses: An online survey in China
2020 · International Journal of Nursing Sciences · 68 citations
https://doi.org/10.1016/j.ijnss.2020.11.006
Occurrence and outcome of de novo metastatic breast cancer by subtype in a large, diverse population
2016 · Cancer Causes & Control · 59 citations
https://doi.org/10.1007/s10552-016-0791-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat